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Introduction:
Adipose stem cells (ASCs) are increasingly being used for aesthetic and reconstructive surgery in multiple surgical disciplines (1) (2) (3) . Their main utility lies in the repair of soft tissue contour deficits either as a result of aging (aesthetic) or tumor removal, trauma, and congenital malformations (reconstructive). While their use in cosmetic surgery is less controversial, there are some lingering doubts about their safety when used at sites of tumor extirpation. Additionally, injection of fat into hormonally sensitive sites such as the breast could carry long-term consequences. Long-term follow up data in these patients are still not available to ascertain the safety of ASCs in these patients. Nonetheless, it is important to investigate the effects of ASCs and adipocytes on cancer cells because of the established link between obesity and cancer (4) . A recent review in Cancer Research identified 37 articles that investigated the influence of ASCs on cancer progression and metastases (5) . ASC-derived factors such as Vascular Endothelial Growth Factor, Interleukin 6 (IL-6), IL-8, Tumor Necrosis Factor Alpha (TNFα), Hepatocyte Growth Factor (HGF), Leptin, and Insulin-like growth factor (IGF) are suggested to promote angiogenesis, inflammation, cell proliferation, and hypoxia in the tumor microenvironment (5-7). Reciprocally, breast tumor cells promote transdifferentiation of ASCs into cancer-associated fibroblasts, which enhance tissue stiffness (8, 9) .
In contrast to ASCs, the role of adipocytes in cancer progression remains controversial. Many reports indicated pro-tumor growth effect including adipocytemediated induction of epithelial to mesenchymal transition (EMT) and resistance to ERBB2-targeted therapy (10, 11) . The adipokine Lipocalin2 secreted by adipocytes 6 linked obesity to breast cancer progression (12) . However, a recent study showed reduced proliferation of breast cancer cells that are in direct contact with neighboring adipocytes (13) .
There are several gaps in our understanding of the role of ASCs and adipocytes on breast cancer. The first, do normal and tumor cells respond similarly to ASCs? Second, to what extent do ASCs alter stem-luminal progenitor-differentiated cell hierarchy in normal and cancer breast epithelial cells? Addressing this question is critical because most breast cancers are believed to originate from luminal progenitor cells (14, 15) . Third, do ASCs and adipocytes have distinct effects on normal and tumor cells and if so, can these differences be attributed to ASCs and adipocytes-enriched chemokines/cytokines? To address the above questions, we utilized an in vitro system where we measured the effects of conditioned medium (CM) from ASCs and ASC derived adipocytes on stem-luminal progenitor-differentiated cell hierarchy under growth conditions that promote self-renewal as well as differentiation of stem cells. Spontaneously immortalized breast epithelial cell line MCF10A, MCF10A cells with enhanced EMT characteristics due to overexpression of SLUG (MCF10A-SLUG) (16), a MCF10A derivative that generates ductal carcinoma in situ (MCF10DCIS.com) (17) and MCF10A cells transformed by the SRC oncogene (MCF10A-SRC) were tested (18) . We demonstrate that ASCs and adipocytes have distinct effects on the hierarchy of immortalized and transformed breast epithelial cells. HGF, secreted at higher levels by ASCs, and interferon gamma (IFNγ), secreted at higher levels by adipocytes, altered breast stemluminal progenitor-differentiated cell profiles. We propose that the inter-individual differences in the ratio of ASCs to adipocytes in fat tissue or the ability of ASCs to 7 differentiate into adipocytes could influence the rate of differentiation of breast epithelial cells with ultimate impact on breast cancer incidence and progression. (18) . SUM225 cells were purchased from Asterand (Detroit, MI) and maintained in media recommended by Asterand. Primary ASCs were isolated from abdomen, hips, axilla and/or flank and cultured as previously described (19) . SUM225 and MCF10DCIS.com cells were purchased for this project alone and were cultured for the first time for this study. MCF10A cells have been authenticated within last two years using STR Systems for Cell line identification (DNA Diagnosis Center, Fairfield, OH). Supplementary Table 1 (Table S1 ) provides details of sites of fat tissue collection, age, and BMI of individuals from whom ASCs were collected. All procedures of collecting human adipose tissue were approved by the Indiana University School of Medicine Institutional Review Board. All samples were from females. These ASCs have been characterized by flow cytometry for cell surface markers and for osteogenesis and adipogenesis as described previously (19, 20) . ASCs were subjected to adipocyte differentiation by culturing in adipogenic differentiation media (21) . Conditioned medium (CM) from confluent cultures was used. The mammosphere assay has been described previously (22) . Briefly, 5000 cells were plated on ultra-low adherent six well plates in MammoCult media from Stemcell Technologies 
RNA isolation and quantitative reverse transcription polymerase chain reaction (qRT-PCR):
RNeasy kit from Qiagen (Redwood City, CA) was used to isolate total RNA. qRT-PCR was performed as described previously and expression levels were normalized to 
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Statistical analysis: All data presented are mean ±standard deviation from 2-6 experiments. In experiments with similar trends but with experimental variability, experiments with least variability were selected for statistical analysis. Student t test was used to measure the statistical significance between measurements (Graphpad.com).
Results:
ASCs enhance self-renewal of breast epithelial cells
The mammosphere assay is used routinely as a surrogate assay to measure self-renewal; previous studies in neurosphere cultures have shown that the size of the spheres indicates the extent of self-renewal (24, 25) . We used this assay to determine the effect of ASCs on 
ASCs expand basal/luminal progenitor cell population of MCF10A cells
Breast epithelial cells with basal/stem-like, luminal progenitor, and nonclonogenic/differentiated characteristics display CD49f+/EpCAM-, CD49f+/EpCAM+, and CD49f-/EpCAM+ cell surface marker profile, respectively (26, 27) . We used these two marker combinations to determine the effects of ASCs on phenotype of cells in the 
Transformed cells respond differently to ASC and adipocyte CMs
To determine whether ASCs and adipocytes have different effects on breast epithelial cells, we obtained ASCs from three additional individuals and collected CMs from undifferentiated and adipocyte-differentiated ASCs. CMs from ASCs were more effective than CMs from adipocytes in increasing the size of MCF10A-derived mammospheres ( Figure 3A) . ASC CM (all three) but not adipocyte CM (one out of three) increased the number of CD49f+/EpCAM-cells in the mammospheres (Figure 3B and C).
Note that these three samples were obtained from individuals with higher BMI and ASCs from these individuals increased stem rather than luminal progenitor cells (Compare Figure 5D ).
The cell line SUM225 is also being used as a model for DCIS (33) . Unlike all other cell types tested, SUM225 cells were unresponsive to ASC and adipocyte CM both with respect to mammosphere formation and changes in the marker profiles ( Figure S1 ).
SUM225 cells overexpress ERBB2 oncogene and it is possible that ASCs and ERBB2
activate overlapping signaling pathways to alter differentiation status of breast epithelial cells.
Individual variation in soluble factors secreted by ASCs
We performed cytokine array analysis of ASC CM (two patients) and adipocyte 
HGF/IFNγ mRNA ratio in the breast tumor microenvironment predicts outcome in patients with ER-or PR-breast cancers
Since adipocyte differentiation altered the ratio between HGF and IFNγ, we next determined whether the ratio between these two factors within the breast cancer environment has any prognostic value using a tool we developed recently (34) . 
